

Strongbridge Biopharma is a clinical and financial foundation to connect patients with new treatments for rare diseases. Among its major competitors, Strongbridge Biopharma is ranked in 11th place for NPS while Vertex Pharmaceuticals is 1st, and Biogen is 2nd.Their current market cap is $135.66M